These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7039516)

  • 41. [The French nationwide cystic fibrosis newborn screening program: strategy and results].
    Munck A; Roussey M
    Arch Pediatr; 2008 Jun; 15 Suppl 1():S1-6. PubMed ID: 18822253
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Assay of serum immunoreactive trypsin in dried blood spots and the early detection of cystic fibrosis.
    Ryley HC; Robinson PG; Yamashiro Y; Bradley DM
    J Clin Pathol; 1981 Aug; 34(8):906-10. PubMed ID: 7276210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conclusions from a pilot immunoreactive trypsin newborn screen for cystic fibrosis.
    Kirby LT; Davidson AG; Applegarth DA; Wong LT; Hardwick DF
    Clin Chem; 1983 Aug; 29(8):1559-60. PubMed ID: 6872228
    [No Abstract]   [Full Text] [Related]  

  • 44. Screening for cystic fibrosis among newborns in Norway by measurement of serum/plasma trypsin-like immunoreactivity. Results of a 2 1/2-year pilot project.
    Edminson PD; Michalsen H; Aagenaes O; Lie SO
    Scand J Gastroenterol Suppl; 1988; 143():13-8. PubMed ID: 3164498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of pancreatic function in screened infants with cystic fibrosis.
    Gaskin K; Waters D; Dorney S; Gruca M; O'Halloran M; Wilcken B
    Pediatr Pulmonol Suppl; 1991; 7():69-71. PubMed ID: 1782134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dried blood spot screening for cystic fibrosis.
    Applegarth DA; Davidson AG; Kirby LT; Bridges M; Sorensen P; Wong LT; Hardwick DF
    Lancet; 1979 Dec; 2(8154):1236-7. PubMed ID: 92637
    [No Abstract]   [Full Text] [Related]  

  • 47. [Neonatal cystic fibrosis screening program in the state of Paraná: evaluation 30 months after implementation].
    Santos GP; Domingos MT; Wittig EO; Riedi CA; Rosário NA
    J Pediatr (Rio J); 2005; 81(3):240-4. PubMed ID: 15951909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Non-competitive enzyme immunoassay of human trypsin 1.
    Carrere J; Grataroli R; Marfin J; Ferrua B; Thouvenot JP; Figarella C
    J Immunol Methods; 1983 May; 60(1-2):235-42. PubMed ID: 6343497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood.
    Heeley AF; Bangert SK
    Ann Clin Biochem; 1992 Jul; 29 ( Pt 4)():361-76. PubMed ID: 1642442
    [No Abstract]   [Full Text] [Related]  

  • 50. Diagnostic delay in cystic fibrosis: lessons from newborn screening.
    Wilcken B; Towns SJ; Mellis CM
    Arch Dis Child; 1983 Nov; 58(11):863-6. PubMed ID: 6651321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for cystic fibrosis in the newborn by meconium analysis.
    Ryley HC; Neale LM; Brogan TD; Bray PT
    Arch Dis Child; 1979 Feb; 54(2):92-7. PubMed ID: 312055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Newborn screening for cystic fibrosis: a historical perspective.
    Elliott RB
    Pediatr Pulmonol Suppl; 1991; 7():7-10. PubMed ID: 1782135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trisomy 18, cystic fibrosis, and blood immunoreactive trypsin.
    Heeley AF; Fagan DG
    Lancet; 1984 Jan; 1(8369):169-70. PubMed ID: 6140482
    [No Abstract]   [Full Text] [Related]  

  • 54. The role of the laboratory in the diagnosis of cystic fibrosis.
    Hjelm M; Davey J; Dinwiddie R; Jackson D; Quartey-Papafio P
    Clin Biochem; 1984 Oct; 17(5):284-7. PubMed ID: 6499156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The international quality assurance program (IRTIQAS) for the assay of immunoreactive trypsin in dried blood spots.
    Heeley ME; Travert G; Ferre C; Lemonnier F
    Pediatr Pulmonol Suppl; 1991; 7():72-5. PubMed ID: 1782136
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum-immunoreactive-trypsin concentrations in cystic fibrosis.
    Dandona P; Hodson M; Bell J; Ramdial L; Batten JC
    Lancet; 1979 May; 1(8124):1032. PubMed ID: 86747
    [No Abstract]   [Full Text] [Related]  

  • 57. Abnormal frequency of delta F508 mutation in neonatal transitory hypertrypsinaemia.
    Laroche D; Travert G
    Lancet; 1991 Jan; 337(8732):55. PubMed ID: 1670678
    [No Abstract]   [Full Text] [Related]  

  • 58. Nutritional deficits exist before 2 months of age in some infants with cystic fibrosis identified by screening test.
    Reardon MC; Hammond KB; Accurso FJ; Fisher CD; McCabe ER; Cotton EK; Bowman CM
    J Pediatr; 1984 Aug; 105(2):271-4. PubMed ID: 6747761
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunoreactive trypsin level in fetoscopically-obtained cord sera of second trimester fetuses.
    Ryley HC; Rodeck CH
    Prenat Diagn; 1984; 4(4):303-6. PubMed ID: 6483790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Newborn screening for cystic fibrosis using an enzyme linked immunoabsorbent assay (ELISA) technique.
    Bowling FG; Brown AR
    Clin Chim Acta; 1988 Feb; 171(2-3):257-61. PubMed ID: 3370824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.